Accumulation of mutations in vivo confer cross-resistance to new integrase inhibitors

被引：0
|
作者：
Zhang, W. W. [1 ]
Cheung, P. K. [2 ]
Oliveira, N. S. [2 ]
Robbins, M. [2 ]
Harrigan, P. R. [3 ]
Shahid, A. [2 ]
机构：
[1] Univ British Columbia, Med, Vancouver, BC, Canada
[2] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada
[3] Univ British Columbia, Vancouver, BC, Canada
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2018年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
THPDB0104
引用
收藏
页码：139 / 139
页数：1
相关论文
共 50 条
  • [31] Cross-resistance to different aromatase inhibitors in breast cancer treatment
    Lonning, PE
    ENDOCRINE-RELATED CANCER, 1999, 6 (02) : 251 - 257
  • [32] Cross-resistance of Bidens subalternans to acetolactate synthase inhibitors in Brazil
    Lamego, F. P.
    Vidal, R. A.
    Burgos, N. R.
    Federizzi, L. C.
    WEED RESEARCH, 2009, 49 (06) : 634 - 641
  • [33] In Vitro Properties and Virulence of Contemporary Recombinant Influenza B Viruses Harboring Mutations of Cross-Resistance to Neuraminidase Inhibitors
    Fage, Clement
    Abed, Yacine
    Checkmahomed, Liva
    Venable, Marie-Christine
    Boivin, Guy
    VIRUSES-BASEL, 2019, 11 (01):
  • [34] Cross-resistance patterns to acetyl coenzyme A carboxylase (ACCase) inhibitors associated with different ACCase mutations in Beckmannia syzigachne
    Pan, L.
    Li, J.
    Zhang, T.
    Zhang, D.
    Dong, L. Y.
    WEED RESEARCH, 2015, 55 (06) : 609 - 620
  • [35] Impact of the HIV integrase genetic context on the phenotypic expression and in vivo dynamics of integrase inhibitor resistance mutations
    Nga Nguyen
    Sylvie Rato
    Francois Clavel
    Constance Delaugerre
    Fabrizio Mammano
    Retrovirology, 10 (Suppl 1)
  • [36] Impact of the HIV integrase genetic context on the phenotypic expression and in vivo dynamics of integrase inhibitor resistance mutations
    Nga Nguyen
    Rato, Sylvie
    Clavel, Francois
    Delaugerre, Constance
    Mammano, Fabrizio
    RETROVIROLOGY, 2013, 10 : S25 - S26
  • [37] Protease inhibitors: resistance, cross-resistance, fitness and the choice of initial and salvage therapies
    Erickson, JW
    Gulnik, SV
    Markowitz, M
    AIDS, 1999, 13 : S189 - S204
  • [38] Clinical cross-resistance between the HIV-1 protease inhibitors saquinavir and indinavir and correlations with genotypic mutations
    Schapiro, JM
    Winters, MA
    Lawrence, J
    Merigan, TC
    AIDS, 1999, 13 (03) : 359 - 365
  • [39] Resistance and cross-resistance with saquinavir and other HIV protease inhibitors: theory and practice
    Roberts, NA
    Craig, JC
    Sheldon, J
    AIDS, 1998, 12 (05) : 453 - 460
  • [40] Beware of resistance to 2nd-generation integrase inhibitors: A systematic meta-analysis of HIV-1 integrase inhibitors resistance and drug resistance mutations
    Liu, Shanshan
    Yuan, Defu
    Zhou, Ying
    Wang, Bei
    Hu, Haiyang
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 64 (03)
12345